You are here

Vaccinations

U.S. FDA panel narrowly backs Pfizer RSV vaccine for older adults

...

The Food and Drug Administration panel voted 7-4 on two separate questions of whether Pfizer’s data showed the vaccine was safe and effective against the respiratory virus for people 60 and older. One panelist abstained from voting. The recommendation is non-binding and the FDA will make its own decision on the vaccine in the coming months.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Global COVID cases, deaths continue to drop, new study cites vaccination benefits --WHO

Monthly averages for new COVID-19 cases and deaths continue to decline steadily, the World Health Organization (WHO) said today in its latest pandemic update, though it cautioned that the trends are underestimated due to reduced testing and delayed reporting.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Vaccinations
howdy folks